Integration of GWAS and omics QTL reveals molecular mechanisms underlying neurodegenerative diseases

Poster No:

119 

Submission Type:

Abstract Submission 

Authors:

Haojing Duan1, Yundi Hu2, Xiaolei Lin2, JianFeng Feng1

Institutions:

1Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China, 2School of Data Science, Fudan University, Shanghai, China

First Author:

Haojing Duan  
Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University
Shanghai, China

Co-Author(s):

Yundi Hu  
School of Data Science, Fudan University
Shanghai, China
Xiaolei Lin  
School of Data Science, Fudan University
Shanghai, China
JianFeng Feng  
Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University
Shanghai, China

Introduction:

Global trend of population aging is leading to an increasing prevalence of neurodegenerative diseases (Hou et al., 2019). Recent large-scale Genome-Wide Association Studies (GWASs) and multi-type studies of molecular quantitative trait (molQTL) have enhanced our understanding of trait-associated genetic variations (de Klein et al., 2023; Kibinge et al., 2020). However, most studies integrated only one or a few types of QTLs into analyses and overlooked shared mechanisms underlying neurodegenerative diseases.

Methods:

In this study, we curated the most recent GWAS summary statistics of European ancestry for five neurodegenerative diseases (Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, Lewy body dementia and Parkinson's disease), as well as QTL summary data from blood samples of predominantly European for six molecular phenotypes (gene expression, DNA methylation, chromatin accessibility, histone modification, RNA splicing, protein). Associations between molecular phenotypes and neurodegenerative diseases were identified by jointly analyzing six types of molQTL data with GWAS summary data using OPERA (Omics PlEiotRopic Association) approach (Wu et al., 2023), which is a Bayesian generalization of the summary-data-based Mendelian randomization and heterogeneity independent instruments approach. Next, we performed a genome-wide correlation across five neurodegenerative diseases using multivariable LD-Score regression (LDSC). We calculated a common factor GWAS for these five diseases using genomic structural equation modeling (Genomic SEM) (Grotzinger et al., 2019), which represented a shared genetic basis among neurodegenerative diseases and was subsequently utilized in the identification of pleiotropy associations. Within pleiotropy associations from the common factor GWAS, we performed gene set enrichment analyses for pleiotropy (or causal) molecular phenotypes using clusterProfiler (Wu et al., 2021) and SynGO (Koopmans et al., 2019), and examined brain region expression and cell type expression of shared causal variants based on Allen Human Brain Atlas dataset (Hawrylycz et al., 2012).

Results:

We used OPERA approach to identify pleiotropic associations of different combinations of molecular phenotypes with neurodegenerative diseases. More than one-third of the GWAS signals were shared with at least one molecular phenotype, with DNA methylation and gene expression explaining the most GWAS signals in six types of QTL (Figure 1a). As an example of joint pleiotropic associations, we observed that SLC24A4 and RIN3 genes were associated with Alzheimer's disease jointly with three other types of molecular phenotypes including DNA methylation, histone modification and RNA splicing (Figure 1b). The LDSC demonstrated that neurodegenerative diseases exhibit concordant genetic correlations (Figure 2a), which supports our use of GenomicSEM to derive a common factor that profiles the genetic architecture of five diseases. There were 26 independent significant GWAS signals identified in the common factor GWAS (Figure 2b), of which 40.7% of the GWAS signals could be explained by performing OPERA, including NSF and SNCA genes that are involved in the regulation of multiple diseases. The enrichment analysis indicated that 16p11.2 proximal deletion syndrome, SNARE binding, neurotransmitter release, and membrane fusion are implicated in the shared mechanisms of neurodegenerative diseases (Figure 2c). Furthermore, the shared causal variants were found to present similar expression patterns in some specific brain regions, such as substantia nigra and hippocampus, and were highly expressed in microglia and oligodendrocyte precursor cell (Figure 2d and 2e).
Supporting Image: OHBM_Fig1.png
Supporting Image: OHBM_Fig2.png
 

Conclusions:

Our research identified the molecular phenotypes associated with each neurodegenerative disease, and elucidated the genetic structure and shared molecular mechanism between them, providing insights for the development of precision medicine and therapies.

Disorders of the Nervous System:

Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s) 1

Genetics:

Genetic Association Studies
Genetic Modeling and Analysis Methods 2
Transcriptomics

Keywords:

Degenerative Disease
Phenotype-Genotype
Statistical Methods
Other - multi-omics; genome-wide association studies; pleiotropy analysis; pathway

1|2Indicates the priority used for review

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I do not want to participate in the reproducibility challenge.

Please indicate below if your study was a "resting state" or "task-activation” study.

Other

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Patients

Was this research conducted in the United States?

No

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Yes

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

Not applicable

Please indicate which methods were used in your research:

Computational modeling

Provide references using APA citation style.

Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019). Ageing as a risk factor for neurodegenerative disease. Nature Reviews Neurology, 15(10), 565-581.
de Klein, N., Tsai, E. A., Vochteloo, M., Baird, D., Huang, Y., Chen, C. Y., ... & Westra, H. J. (2023). Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nature genetics, 55(3), 377-388.
Kibinge, N. K., Relton, C. L., Gaunt, T. R., & Richardson, T. G. (2020). Characterizing the causal pathway for genetic variants associated with neurological phenotypes using human brain-derived proteome data. The American Journal of Human Genetics, 106(6), 885-892.
Wu, Y., Qi, T., Wray, N. R., Visscher, P. M., Zeng, J., & Yang, J. (2023). Joint analysis of GWAS and multi-omics QTL summary statistics reveals a large fraction of GWAS signals shared with molecular phenotypes. Cell Genomics, 3(8).
Grotzinger, A. D., Rhemtulla, M., de Vlaming, R., Ritchie, S. J., Mallard, T. T., Hill, W. D., ... & Tucker-Drob, E. M. (2019). Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nature human behaviour, 3(5), 513-525.
Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai, Z., ... & Yu, G. (2021). clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The innovation, 2(3).
Koopmans, F., van Nierop, P., Andres-Alonso, M., Byrnes, A., Cijsouw, T., Coba, M. P., ... & Verhage, M. (2019). SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron, 103(2), 217-234.
Hawrylycz, M. J., Lein, E. S., Guillozet-Bongaarts, A. L., Shen, E. H., Ng, L., Miller, J. A., ... & Jones, A. R. (2012). An anatomically comprehensive atlas of the adult human brain transcriptome. Nature, 489(7416), 391-399.

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No